Document is current

Any future updates will be listed below

A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S-1 for borderline-resectable pancreatic cancer with arterial involvement

Crossref DOI link: https://doi.org/10.1007/s00280-017-3288-7

Published Online: 2017-04-04

Published Print: 2017-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark